Continuously evolving venues, methods, and targets of patent litigation; the new USPTO director; patent reform bills … these are just a few factors challenging Japanese IP executives’ already complex task of trying to manage their global IP footprint smarter.
In this half-day, complimentary seminar, former USPTO Director Jon W. Dudas and a group of U.S., Japanese, and Chinese IP attorneys experienced in advising Japanese corporations decipher what really matters for Japanese businesses as U.S. patent procurement and enforcement regimes are being radically restructured. The topics included:
- The New Administration and Director Kappos – What Happens Next?
- The effect on the Patent Reform Act of 2009
- What will become of the Tafas v. Doll rules package and the interpretation of Bilski?
- How might the rules on inter partes reexamination be tightened?
- Strategic Use of Inter Partes Reexamination in Patent Litigation
- In synergy with expected procedural changes under the new USPTO director, the very high kill ratio of patents makes inter partes reexamination a very attractive alternative or parallel to district court litigation
- Pros and cons vs. alternatives
- Mistakes to avoid
- Strategic Measures for Effective and Efficient U.S. Patent Litigation
- Focused discovery, management controls, and other tactical measures to achieve litigation goals without undue costs
- Positioning a company to exit litigation early
- Latest considerations for transferring away from certain “Rocket Dockets”
- Chinese Infringement Under the Third Amendment:
- Milestones for claim and patent application drafting and claim interpretation based on the draft interpretation of patent infringement principles issued by the highest court in China
- Comparative analyses of the Chinese patent law with reference to Japanese and U.S. patent principles
Guest Speakers
- Dr. Hiroshi Akimoto, former Managing Director, Takeda Pharmaceutical Company, Ltd.
- Shozo Uemura, former Deputy Director General, WIPO
폴리 스피커
- Jon W. Dudas, former Director of USPTO and Partner, IP Litigation
- Pavan K. Agarwal, Partner and Chair, Electronics
- Etsuo Doi, Partner, Electronics, Tokyo
- Stephen B. Maebius, Partner and Co-Chair, Life Sciences Industry Team
- Prof. Harold C. Wegner, Partner, Chemical & Pharmaceutical
- Yan Zhao, Senior Counsel, Electronics, Shanghai
For specific information on the content of this seminar, contact Konomi Kaji at [email protected].
사람
관련 인사이트
December 12, 2025
Health Care Law Today
Eleventh Circuit Hears Oral Argument in Landmark Constitutional Challenge to False Claims Act’s Qui Tam Provisions
On December 12, the U.S. Court of Appeals for the Eleventh Circuit heard oral argument in U.S. ex rel. Zafirov v. Florida Medical…
2025년 12월 11일
폴리 뷰포인트
지식재산권 포트폴리오 관리에서의 반독점 위험 및 준수 전략
본 논문은 지식재산 포트폴리오 관리가 어떻게 혁신을 촉진함과 동시에 잠재적 위험을 제시할 수 있는지 분석한다.
2025년 12월 11일
폴리 뷰포인트
캘리포니아 대기질 관리국(CARB), SB 261 및 253 법안에 대한 규정안 발표
2025년 12월 9일, 캘리포니아 대기 자원 위원회(CARB)는 초기 규정을 위한 제안된 규제 문안을 발표했습니다…